Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
08/2003
08/06/2003CN1434026A Process for prepraring p-acetpamidophenol
08/06/2003CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
08/06/2003CN1117055C Pesticide compounds, compositions and process for preparation thereof
08/05/2003US6603044 Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same
07/2003
07/31/2003WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003WO2003062143A1 Preparation of non-hazardous brominating reagents
07/31/2003WO2003061768A2 Use of a compound inactivating the kinase a protein in a composition containing a cosmetically acceptable medium in order to lighten the skin
07/31/2003WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003US20030144344 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile
07/31/2003US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis
07/31/2003US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans
07/31/2003US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases
07/31/2003US20030144214 Alkyl amino acid derivatives useful as pharmaceutical agents
07/31/2003US20030144139 Novel phosphine compound, transition metal complex containing the same phosphine compound as ligand and asymmetric synthesis catalyst containing the complex
07/31/2003US20030144138 Having chemical selectivity, enantioselectivity, catalytic activity; for use as a catalyst for asymmetric syntheses, especially asymmetric hydrogenation
07/31/2003US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
07/31/2003US20030143188 Ingestibles possessing intrinsic color change
07/31/2003CA2473545A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/30/2003EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/30/2003EP1330430A2 Integrin receptor inhibitors
07/30/2003EP1330429A2 Alkynyl amides and their therapeutic applications
07/30/2003CN1433401A New phenalkyloxy-phenyl derivatives
07/30/2003CN1433397A Method for the prepararation of enantiomerically enriched compounds
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1433274A Sweeteners pariticularly for coffee and tea
07/30/2003CN1432558A Production process of dialkyl formamide
07/30/2003CN1116276C Process for synthesizing N-(3'-isopropropoxyphenyl)-2-methyl benzoylamine
07/29/2003US6600074 Perfluoroalkylated aniline compound and process for producing the same
07/29/2003US6600069 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example
07/29/2003US6600063 Novel antimycobacterial compounds and in particular to antimycobacterial compounds comprised of derivatives of phenyl 4-aminosalicylate. This invention further relates to methods for their preparation, to form drugs
07/29/2003US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting
07/29/2003CA2348182C Novel complex and emulsified composition
07/24/2003WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003WO2003059866A1 Geranyl compounds
07/24/2003WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
07/24/2003WO2003031456A3 Ligands for asymmetric reactions
07/24/2003US20030139475 Novel tricyclic compounds and drug compositions containing same
07/24/2003US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
07/24/2003US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
07/24/2003US20030139285 Novel asymmetric phosphine ligand
07/24/2003US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product
07/24/2003US20030136941 Preparation of non-hazardous brominating reagents
07/24/2003CA2706833A1 Geranyl compounds
07/24/2003CA2706826A1 Geranyl compounds
07/23/2003EP0898559B1 Cytoprotective compounds
07/23/2003EP0804411B1 Synthetic polyunsaturated fatty acid analogues
07/23/2003CN1431996A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
07/23/2003CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol
07/22/2003US6596898 Making a 2-fluoro-2-chlorocyclopropanecarboxylic acid derivative stereoselectively in high yield by reacting a diazoacetic acid derivative with 1-fluoro-1-chloroethylene using metal catalyst having chiral ligands
07/22/2003US6596884 Synthesis of hydrogen peroxide
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596773 Central nervous system disorders
07/22/2003US6596752 Inhibitors of α4β1 mediated cell adhesion
07/22/2003US6596743 Carbamic acid derivatives
07/22/2003US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
07/17/2003WO2003057662A2 Acylated ethylenediamine disuccinate
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003WO2003003987A3 Solid phase synthesis of arylretinamides
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex
07/17/2003US20030133904 Sphingolipids
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides
07/16/2003EP1326825A2 Compounds and compositions for delivering active agents
07/15/2003US6593363 The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1).
07/15/2003US6593314 Useful in the inhibition of neuraminidase enzymes from disease- causing microorganisms, especially influenza neuraminidase, pharmaceutical formulations containing same, processes and intermediates for preparing said compounds,
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/15/2003CA2218766C Bicyclic-aromatic compounds
07/10/2003WO2003055923A1 Novel monomers useful in the preparation of separation matrices
07/10/2003WO2003055867A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators
07/10/2003WO2003055846A1 Diaminodicarboxylic acids and intermediates thereof
07/10/2003WO2003055843A1 Agaricoglycerides and analogs
07/10/2003WO2002020464A8 Benzene tricarboxylic acid amides as insulin receptor activators
07/10/2003WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130509 Process to produce 3-carbon amino alcohol salts
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003US20030130161 Highly concentrated coconut amido propyl betaine
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
07/09/2003EP1325013A2 Catalyst for asymmetric (transfer) hydrogenation
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP1066244B1 Method for producing 2,4-dichloro-5-hydroxyacetanilide
07/09/2003EP0901483B1 Benzofurans and benzopyrans as chronobiological agents
07/09/2003CN1429199A Insecticidal 1,8-naphthalenedicarboxamides
07/09/2003CN1429198A Novel phenyl-proparylether derivatives
07/09/2003CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
07/09/2003CN1428334A Alkaloid compound, pain-stopping medicine and its preparation method
07/09/2003CN1113857C Nonionic surface active agent for tertiary oil recovery and its production method
07/09/2003CN1113834C Separating agent for optical isomers, and its use and process for producing same
07/08/2003US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes)
07/08/2003US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
07/08/2003US6589976 Particularly effective wood preservation is achieved by impregnation processes on a large industrial scale, for example vacuum, a double vacuum or pressure processes.
07/08/2003US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
07/03/2003WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them